Clinical Trial Update: A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of TAK-228 in combination with TAK-117 in adults with advanced nonhematologic malignancies completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonhematologic Malignancies

Drugs mentioned

• TAK-117
• TAK-228

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Nonhematologic Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2019-10-30